Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.

Finerenone vs Spironolactone Real-World Data Comparison for Cardiorenal & Heart Failure Treatment

Finerenone vs Spironolactone: A Head-to-Head Look at Safety and Efficacy

Finerenone vs spironolactone: head-to-head real-world data shows finerenone has 69% lower mortality, 53% fewer kidney events, and less hyperkalemia. Nonsteroidal MRA with no hormonal side ...

Clascoterone 5% Topical Solution Phase 3 Data for Androgenetic Alopecia | Mechanism & Safety Analysis

Clascoterone for Hair Loss: What the Phase 3 Data Actually Show

Clascoterone for hair loss: Phase 3 trials show significant regrowth with minimal systemic absorption. How it works, side effects, and comparison to finasteride.

GLP-1 drug academic research, pharmaceutical intermediates analysis, clinical study of orforglipron weight loss medicine

Does GLP-1 Cause Hair Loss? What I Learned From Reading the Studies

Does GLP-1 cause hair loss? Yes, studies on 1.1M+ patients show an association—driven by rapid weight loss, not direct drug toxicity. Telogen effluvium is temporary. ...

Orforglipron vs Tirzepatide GLP-1 drug comparison infographic with clinical trial data, pharmaceutical small molecule and peptide agonist analysis for metabolic disease and high-purity intermediates

Orforglipron vs Tirzepatide: A Data Driven Comparison

Comparing orforglipron vs tirzepatide: tirzepatide shows greater weight loss (-20.9% vs -12.4%), but orforglipron offers oral dosing, easier manufacturing, and potential for better long-term adherence.

Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.

Quick Links

Contact us